MALCISBO
Malcisbo develops novel carbohydrate-based vaccines for human and animal health. Their focus is on parasitic diseases, on human food safety and on zoonotic diseases. The company has developed its proprietary target discovery platform to identify carbohydrates as vaccine targets. Combined with their glycoengineering technologies, novel and efficient glycoconjugate vaccines are being developed. Malcisbo is developing a strong pipeline of novel vaccine products coming out this platform for unmet needs in human and veterinary medicine targeting large markets. It is Malcisbo’s goal to develop affordable vaccines to protect people in underdeveloped areas against parasitic worm infections (e.g., helminthic infections by hookworm, filaria or schistosoma).
MALCISBO
Industry:
Biotechnology Health Care Medical Test And Measurement
Founded:
2010-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.malcisbo.com
Total Employee:
1+
Status:
Active
Contact:
41 44 633 78 87
Email Addresses:
[email protected]
Total Funding:
130 K CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Nginx Euro JsDelivr
Similar Organizations
Canostix
Canostix is developing a multi-cancer screening blood test that combines photonics and machine learning.
VLPbio
VLPbio focuses on research and development of chimeric virus like particles (VLPs) as vaccines in animal and human health.
Wellcome Trust
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.
Investors List
Venture Kick
Venture Kick investment in Pre Seed Round - Malcisbo
Venture Kick
Venture Kick investment in Grant - Malcisbo
Official Site Inspections
http://www.malcisbo.com
- Host name: rlx2.loginserver.ch
- IP address: 116.202.48.150
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
